Research & Development

The landscape of modern oncology is currently witnessing a tectonic shift as clinical researchers increasingly abandon the cumbersome laboratory-based cell modification protocols that have defined the last decade. For several years, the medical community viewed Chimeric Antigen Receptor (CAR)

The landscape of oncology is shifting as researchers uncover ways to bypass the treatment resistance that typically limits the life expectancy of patients with advanced non-small cell lung cancer. In a field where standard therapies often provide only a few months of additional survival for those

Biological systems are increasingly recognized not just as chemical factories but as mechanical engines where the physical resistance of surrounding tissue determines the fate of a malignant cell. This realization has catalyzed a profound shift in oncology, moving focus from purely genetic

The modern medical landscape is shifting toward a more holistic interpretation of preventative diagnostics, where a single scan can provide a comprehensive overview of a patient’s internal physiological state. Recent clinical observations indicate that low-dose computed tomography (LDCT) scans,

Inside the microscopic battlefield of a human tumor, the difference between a patient’s recovery and a lethal progression often hinges on the metabolic stamina of a single type of immune cell. In the high-stakes battle against malignancy, the CD8+ T cell acts as the body’s elite soldier, but even

Ivan Kairatov is a seasoned biopharma expert whose career has been defined by a deep commitment to unraveling the complexities of tech-driven innovation within the life sciences. With extensive experience in research and development, he has spent years bridging the gap between molecular discovery